Enabling scalable and cost-efficient future healthcare solutions with autonomous health monitoring is the most important driver for Medicubex, headquartered in Helsinki, Finland. Innokas Medical is...
Recent Posts
Three manufacturing sites offer flexible contract manufacturing and agile capacity increasing adjusting to customer-specific needs.
FlowOx 2.0, developed in co-creation between Norwegian company Otivio AS and Innokas Medical, is a clinically promising, patented and cost-efficient home treatment solution for Peripheral Arterial...
The Innovation Voucher, offered by Business Finland, is one funding opportunity for Finnish SMEs who seek for purchasing new knowledge and skills for their business. According to Business Finland,...
Headquartered in Helsinki, Finland, MEGIN is the global leader for magnetoencephalography (MEG) technology used for their non-invasive functional brain mapping solution. A long-term collaboration...
Innokas Medical, with expertise dedicated to medical devices and software, and Biocodex PhaMe, providing pharmaceutical consultant services, have agreed on a strategic partnership. Through this...
In Finland, we celebrate our 103 years of independence today. Innokas Medical wishes everyone a happy Finnish Independence Day! đź’™ #Suomi103
Mr. Janne Kostamo (Executive MBA, M.Sc. in Industrial Eng. and B.Sc. in Mech. Eng.) has been appointed as new CEO of Innokas Medical. 50-year old Kostamo brings 18 years of experience in...
With their next-generation innovation, Synoste aims to renew surgical treatment related to bone deformities. Innokas Medical is involved in this mission by being one of Synoste's co-creation partners...
